Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caila B Vaughn

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Safety|August 4, 2020
Long-term drug treatment in multiple sclerosis: safety success and concernsDejan Jakimovski, Caila B Vaughn, Svetlana Eckert, et al.
Journal of the Neurological Sciences|June 27, 2021
Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosisDejan Jakimovski, Robert Zivadinov, Caila B Vaughn, et al.
Multiple Sclerosis and Related Disorders|May 15, 2020
Tonsillectomy in multiple sclerosis patients: Retrospective, case-controlled, exploratory studyDejan Jakimovski, Muhammad K Ahmed, Caila B Vaughn, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 14, 2020
Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic ThrombolysisAshkan Mowla, Harshit Shah, Navdeep Singh Lail, et al.
Patient Related Outcome Measures|December 19, 2019
Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and PerspectivesOsman Ozel, Caila B Vaughn, Svetlana P Eckert, et al.
Cancer Causes & Control : CCC|August 18, 2023
Sleep duration and mortality among breast cancer survivors in the Western New York Exposures and Breast Cancer (WEB) StudyNisha M Nair, Caila B Vaughn, Heather M Ochs-Balcom, et al.
Journal of the Neurological Sciences|October 25, 2016
Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer riskDeeya Gaindh, Katelyn S Kavak, Barbara Teter, et al.
Neurodegenerative Disease Management|February 13, 2023
Patient-reported outcomes are the strongest predictors of disease disability in intramuscular interferon β-1a usersCaila B Vaughn, Katelyn S Kavak, Dejan Jakimovski, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 10, 2021
Does Body Mass Index Impact the Outcome of Stroke Patients Who Received Intravenous Thrombolysis?Maria Daniela Zambrano Espinoza, Navdeep Singh Lail, Caila B Vaughn, et al.
Gastroenterology Research|November 16, 2013
No Association between Circulating Levels and Genetic Variants of IL-6 and TNF-α and Colon AdenomaCaila B Vaughn, Heather M Ochs-Balcom, Jing Nie, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Safety|August 4, 2020
Long-term drug treatment in multiple sclerosis: safety success and concernsDejan Jakimovski, Caila B Vaughn, Svetlana Eckert, et al.
Journal of the Neurological Sciences|June 27, 2021
Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosisDejan Jakimovski, Robert Zivadinov, Caila B Vaughn, et al.
Multiple Sclerosis and Related Disorders|May 15, 2020
Tonsillectomy in multiple sclerosis patients: Retrospective, case-controlled, exploratory studyDejan Jakimovski, Muhammad K Ahmed, Caila B Vaughn, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 14, 2020
Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic ThrombolysisAshkan Mowla, Harshit Shah, Navdeep Singh Lail, et al.
Patient Related Outcome Measures|December 19, 2019
Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and PerspectivesOsman Ozel, Caila B Vaughn, Svetlana P Eckert, et al.
Cancer Causes & Control : CCC|August 18, 2023
Sleep duration and mortality among breast cancer survivors in the Western New York Exposures and Breast Cancer (WEB) StudyNisha M Nair, Caila B Vaughn, Heather M Ochs-Balcom, et al.
Journal of the Neurological Sciences|October 25, 2016
Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer riskDeeya Gaindh, Katelyn S Kavak, Barbara Teter, et al.
Neurodegenerative Disease Management|February 13, 2023
Patient-reported outcomes are the strongest predictors of disease disability in intramuscular interferon β-1a usersCaila B Vaughn, Katelyn S Kavak, Dejan Jakimovski, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 10, 2021
Does Body Mass Index Impact the Outcome of Stroke Patients Who Received Intravenous Thrombolysis?Maria Daniela Zambrano Espinoza, Navdeep Singh Lail, Caila B Vaughn, et al.
Gastroenterology Research|November 16, 2013
No Association between Circulating Levels and Genetic Variants of IL-6 and TNF-α and Colon AdenomaCaila B Vaughn, Heather M Ochs-Balcom, Jing Nie, et al.
Pageof 3